pianochief92
About
BCR-ABL1 log doubling occasion as a forecaster with regard to treatment-free remission malfunction following imatinib discontinuation within chronic myeloid leukaemia throughout persistent period.
BCR-ABL1 log doubling occasion as a forecaster with regard to treatment-free remission malfunction following imatinib discontinuation within chronic myeloid leukaemia throughout persistent period.